Foghorn Therapeutics, Inc. (FHTX)
4.44
-0.04
(-0.89%)
USD |
NASDAQ |
Dec 12, 16:00
4.44
0.00 (0.00%)
After-Hours: 20:00
Foghorn Therapeutics Profit Margin (Quarterly): -194.4% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| GT Biopharma, Inc. | -- |
| Recursion Pharmaceuticals, Inc. | -3.14K% |
| Erasca, Inc. | -- |
| OmniAb, Inc. | -738.1% |
| CEL-SCI Corp. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -24.76% |
| Gross Profit Margin (Quarterly) | 88.96% |
| Operating Margin (Quarterly) | -226.9% |
| Return on Net Operating Assets | -261.4% |